CTU2 and neoplasm: By comparing tumor burden in each group, we found tumors generated from CTU2 knockdown cells with T0901317 treatment were the smallest (Fig. 4a), indicating that blocking CTU2 may improve the anti-tumor effect of LXR ligands.